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Abstract 
In biomedical science, data mining techniques have been applied to extract statistically significant and clinically useful information from a 
given dataset. Finding biomarker gene sets for diseases can aid in understanding disease diagnosis, prognosis and therapy response. Gene 
expression microarrays have played an important role in such studies and yet, there have also been criticisms in their analysis. Analysis of these 
datasets presents the high risk of over-fitting (discovering spurious patterns) because of their feature-rich but case-poor nature. This paper 
describes a GA-SVM hybrid along with Gaussian noise perturbation (with a manual noise gain) to combat over-fitting; determine the strongest 
signal in the dataset; and discover stable biomarker sets. A colon cancer gene expression microarray dataset is used to show that the strongest 
signal in the data (optimal noise gain where a modest number of similar candidates emerge) can be found by a binary search. The diversity of 
candidates (measured by cluster analysis) is reduced by the noise perturbation, indicating some of the patterns are being eliminated (we hope 
mostly spurious ones). Initial biological validated has been tested and genes have different levels of significance to the candidates; although the 
discovered biomarker sets should be studied further to ascertain their biological significance and clinical utility. Furthermore, statistical validity 
displays that the strongest signal in the data is spurious and the discovered biomarker sets should be rejected. 
 
© 2010 Published by Elsevier B.V. 
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1. Introduction 
Data mining refers to the interdisciplinary field that explores the variety of techniques used to find influential and important 
information or knowledge from a large dataset. Feature selection is a common data mining task, where the most important and 
influential features are extracted in order to make a decision, which for purposes of this paper will be classification. The common 
techniques used for feature selection can be broken into three categories: filter, wrapper and ensemble methods. (Dupuy, et al., 
2007) Most algorithms implemented fall under the filter category, where statistics (t-test, fold change, and PCA) and clustering 
are used to reduce the dimensionality of the problem and then perform the classification. (Eschrich, et al., 2005; Loboda, et al., 
2011; Smith, et al., 2009) An example of an ensemble method is discussed by the work of Qiu et al. (2005) with their ensemble 
dependence model. The method presented here uses elements of all three categories, but may be characterized primarily as a 
wrapper technique This is because it uses a feature selection technique, a genetic algorithm (GA) that is “wrapped around” a 
classifier, a support vector machine (SVM). This wrapper method exploits the interactions between the probes in the dataset. The 
use of an SVM provides the potential of non-linear interactions to be considered. In biomedical science, the analysis of gene 
expression microarray data is of great interest, since genetic markers for the diagnosis, prognosis and drug effectiveness could be 
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valuable if discovered. (Golub, et al., 1999; van't Veer, et al., 2002) These datasets unfortunately tend to be feature-rich but case-
poor, thus spurious/over-fit patterns can be easily found.  
Over-fitting is a phenomenon observed in several machine learning applications, where spurious patterns are identified in the 
data. These spurious patterns are ones that are present in the data, but often have nothing to do with the underlying relationships 
(mapping between inputs and known output) of the data. (Zhang, 2006) Several weaknesses within data cause over-fitting, such 
as measurement noise, lack of data and the feature-rich while case-poor nature. This creates an under-determined system that is 
extremely prone to over-fitting. The consequence of discovering these over-fit, spurious patterns is that the performance on 
unseen data is very poor. Classic methods for combating over-fitting (short of acquiring more cases) are cross-validation and 
noise perturbation. (Dupuy, et al., 2007) The method applied in this paper employs both, though in a novel way. 
Colorectal cancers are the fourth most common cancer diagnosis in the United States. Most colorectal tumors arise from 
epithelial cells (95% of all cases) lining the colon and rectum as a result of stepwise progressive alteration in tumor-suppressor 
genes and oncogenes. (Fearon, et al., 1990) Treatment of the disease is stage specific and becomes more difficult as the disease 
progresses, thus early detection of the disease is imperative. To improve early detection, characterize the progression of the 
disease and increase survival rates the discovery of clinically useful biomarker sets is of great importance. 
 
2. Methods 
The dataset analyzed includes 104 colon cancer patients, all of whom have been clinically diagnosed with the disease. Each 
patient was monitored to determine their 36 month prognosis; by utilizing the monitoring time and status at last contact. Tissue 
samples for each patient were collected during surgical resection and arrayed on the Affymetrix HG-133+ GeneChip. This chip 
includes 54,675 Affymetrix probes for each patient and the robust multi-array (RMA) algorithm (Bolstad, et al., 2003) was used 
to normalize the raw microarray image. 
As an initial reduction step two filter methods of feature selection, t-test and variance pruning, are performed. The t-test 
selected probes that distinguish (different mean distributions) between good and poor prognosis (p-value < 0.05). The variance 
pruning selected the probes that had a significant expression difference (variance greater than 0.45) among all patients (good and 
poor prognosis). The t-test and variance pruning reduce the feature set first to 5,157 and then to 203. In addition biologically 
relevant probes (osteopontin; functioning of chemokines, proteasome, integrins, collagen and fibronectin; Wnt, TGF-β and 
VEGF signaling pathways) were added to the feature set. (Jorissen, et al., 2009) With these 271 probes an efficient search 
strategy must be implemented to find the best combinations (out of all 1081 possible solutions) for the prognosis of colon cancer.  
The GA-SVM hybrid presented here is the exact one from our earlier work with a similar colorectal cancer microarray 
dataset. (Mathur, et al., 2010) This algorithm uses the CHC GA (Eschelman, 1991) with the subset size (SSS) operator (Schaffer, 
et al., 2005) to perform a more global search for the optimal probe subset under cross-validation. The CHC GA includes several 
unique operators including creating diverse children (disruptive recombination), defense against genetic drift (incest prevention) 
and defense against early convergence (soft restart). The system uses SVM perf (Joachims, 2005 and 2006), which optimizes the 
separating hyper plane between the two classes by minimizing the measure of performance (Az value or ROC area). To further 
overcome the over-fit patterns, a noise perturbation was implemented. The original expression values were perturbed according 
to the following equation.  
 
     ࡱࡼሺ࢏ǡ ࢐ሻ ൌ ࢻࡺ࢕࢘࢓ࢇ࢒ሾ૙ǡ ૚ሿ ൅ࡱࡻ࢘࢏ࢍሺ࢏ǡ ࢐ሻࢌ࢕࢘ࢇ࢒࢒࢏ǡ ࢐ 
Where α is a manually adjustable noise gain, Normal[0, 1] is a random value from a normal distribution with a mean of zero and 
standard deviation of one, EOrig is the original expression value and EP is the perturbed expression value. This perturbation is 
implemented in every generation of the GA (although α stays constant for each search), thus improving the robustness of 
resultant probe sets. The overall system is displayed in figure 1, where the GA determines the probe subset and SSS value, thus 
defining the subset of the data that the SVM will utilize. The SVM returns the fitness (Az value or ROC area) and SSS value for 
the test set, which the GA uses in a hierarchical selection manner (higher fitness and lower SSS value is sought). The first line of 
defense to over-fitting is cross-validation in each generation, where 80% and 20% of the data is selected as the training and 
testing sets, respectively. The second line of defense against over-fitting is noise perturbation, which is conducted every 
generation before the data is split into training and testing sets. 
 
Figure 1: Overall GA-SVM System with Noise Perturbation Implementation 
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To find the ideal noise gain value, which result in a modest number of candidates a binary search is conducted. The candidate 
analysis implemented is the same as our previous work. (Mathur, et al., 2010) To assess the diversity among candidates, 
candidates from independent GA-SVM searches (with a common noise gain) were pooled and hierarchical clustering was 
performed. The hierarchy is constructed by first considering each candidate as its own cluster and then clusters are combined 
iteratively until all candidates are in one cluster. The decision to combine clusters is determined by the linkage function, 
implemented by the Ward ESS measure. (Ward Jr, 1963) The distance function implemented is the number of unique probes. 
With the implementation of noise perturbation and cluster analysis we seek that the dissimilarity of cumulative candidates (from 
searches with a common noise gain) stabilizes to a modest number of candidates. 
 
3. Results 
Table 1 shows the results of the binary search for several noise gain (α) values. The table displays the most frequent 
individual genes (probes sampled in the GA extremely more frequently than the others); average fitness of the last 100 
generations; and average subset size (SSS) of the chromosomes in the last generation for each search. Also candidate analysis 
results for the number of candidates (strict and loose criteria), average evaluations, average fitness and average SSS of the 
candidates are shown in table 1. With no perturbation implementation (α = 0), the average fitness is very high and a high number 
of candidates emerge. With a very high noise gain value (α = 0.88 and 1.75) the fitness decreases significantly and no probe sets 
meet the criteria to be considered a candidate. By the binary search the noise gain is decreased by half (α = 0.44) and several 
searches (not all shown) were performed. These results show a slightly lower fitness, although a reasonable number of candidates 
emerge in most of the searches. This provides optimism that the ideal noise gain value (sweet spot) is around this value. To 
explore this area further noise gains of 0.22, 0.33 and 0.4 are tested. At a noise gain of 0.22 and 0.33 a large number of 
candidates emerge, thus indicating over-fitting. At a noise gain of 0.4 a reasonable number of candidates and high performance 
for the search is seen. The area above the sweet spot was tested with noise gain values of 0.47, 0.5 and 0.66. The searches for 0.5 
and 0.66 show lower fitness compared to other searches and no emerging candidates. This indicates that the maximum bound of 
the noise gain value (wipeout signal) is at most 0.5. At a noise gain of 0.47, a reasonable number of candidates emerge and the 
fitness is about the same. With the results displayed the sweet spot is narrowed down to values between 0.4 and 0.47. For all 
perturbation searches the fitness of resultant candidates was considerably high (good performance on test data) and the number of 
probes was between seven and ten (number of probes included in the candidate). Comparing the most frequent individual probes 
for all perturbation searches showed a lot of similarity. Although we seek repeat probe sets and all candidates that emerge 
contain many of the most frequent genes, but with some unique genes. Since we initially were looking for exact repeat candidates 
and did not find this characterisitic in any of these searches, cluster analysis is performed on all searches that resulted in 
candidates. 
 
Full Search Characteristics Candidate Analysis 
Noise 
Gain (α) 
Most Frequent Individual 
Probes 
Avg 
Fitness 
Avg 
SSS 
Num. of 
Candidates 
Avg 
Evals 
Avg 
Fitness 
Avg 
SSS 
0 “2,8,9,41,53,56,82,128,153“ 88.13 10.60 12 to 26 25.81 93.37 12.89 
0.22 “15, 23, 26, 66, 102, 133, 153” 82.71 7.45 1 to 19 28.26 84.41 7.63 
0.33 “2, 9, 15, 89, 153” 80.56 6.12 0 to 4 12.50 82.64 6.50 
0.4 “4, 8, 9, 82, 102, 153“ 83.13 9.06 1 to 7 28.86 86.45 9.43 
0.4 “4, 8, 57, 82, 91, 102“ 77.79 6.02 0 to 11 13.00 82.03 7.09 
0.44 “4, 8, 9, 57, 82, 102, 133, 153“ 79.99 8.86 2 to 4 15.25 83.80 9.25 
0.44 “2, 4, 8, 9, 82, 153“ 80.60 7.24 1 10.00 86.23 8.00 
0.47 “4, 8, 9, 91, 102, 153“ 79.70 6.98 0 to 1 10.00 94.44 9.00 
0.47 “2, 10, 15, 46, 102, 133, 153“ 77.19 7.19 0 to 1 10.00 77.88 9.00 
0.5 “4, 9, 15, 153, 166“ 75.75 5.42 0 N/A N/A N/A 
0.66 “4, 8, 82, 102“ 71.65 7.28 0 N/A N/A N/A 
0.88 “4, 8, 102, 153“ 65.18 8.76 0 N/A N/A N/A 
1.75 None 47.68 19.54 0 N/A N/A N/A 
Table 1: Search characteristics and candidate Analysis of Searches from the Noise Gain Sweet Spot 
  
Hierarchical clustering was performed on all candidates resulting from a common noise gain value (different random seeds). 
Figure 2a shows the dendrogram plot of candidates resulting from searches with a noise gain of 0.4, 0.44 and 0.47 (the sweet 
spot). It is apparent that clustering of the candidates does occur. The colors display the different searches (random seeds) from 
which that candidate arose. The candidates do particularly cluster by search, although some searches have candidates throughout 
the plot. The y-axis in this plot is the Ward measure (dissimilarity of candidates connected at that point). The resulting candidates 
indicate that those candidates have the most probes in common.   
To find stability in the biomarker sets with this cluster analysis, the cumulative Ward ESS value (where all objects are in one 
cluster) is calculated iteratively by adding candidates from independent searches (same noise gain value) and running the cluster 
analysis. This plot is shown in figure 2b. The no noise curve shows a very fast increase in the overall dissimilarity and very slight 
convergence. Although this stability is at a very high dissimilarity measure of 233.138 and most probably if more searches are 
conducted the dissimilarity will increase further. The searches with a noise gain of 0.22 show similar behavior, although the 
stability is half the value, at 102.259. The searches with a noise gain of 0.33 shows a possible reasonable stability point at 33.654. 
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The searches within the sweet spot of noise gain (0.4, 0.44, and 0.47) show a significant stability of the similarity of the 
biomarker sets to 37.8751. This means that the system at this noise level finds very similar biomarker sets repeatedly. 
Further analysis of the candidates from the 
sweet spot searches identified the relative 
importance of each of the probes in each candidate. 
Thirty-eight candidates emerged from the searches 
in the sweet spot of the noise gain values (table 2), 
which contained sixty-two different probes. The 
probes have many similarities to another 
idenpendent system (Land et al., 2011) that 
involves using Partial Least Squares. To validate 
these discovered candidates biological and 
statistical validity was examined. To display 
biological significance, network analysis was 
conducted. Each probe is displayed in two network 
graphs in figure3. Figure 3a displays an undirected 
network of the sixty-two probes. An edge is 
defined as the nodes (probes) are in the same 
candidate. Thus each candidate is a fully connected 
(a)              subgraph within this undirected gene network. This 
network shows that several probes are core or 
“must-have” members of the candidates (high 
connected nodes in the middle of the network). 
As you move from nodes in the inner  
section of this network towards nodes in the outer 
section of the network the node degree decreases. 
This degree of a node indicates the relative 
importance of that node, where three catergories 
can be stated, “must-haves”, “nice-to-have”, and 
“uniques”. 
These categories are further examined in the 
directed gene network (figure 3b). Each edge in 
this network is defined as the nodes are in the 
same candidate and the direction of the edge is 
from the higher degree node to the the lower 
degree node, in terms of the degrees in the 
undirected gene network (figure 3a). Each 
candidate in this network will be a distinct path 
(b)               (one is displayed in red) in the network.    
Figure 2: (a) Dendrogram Plot of Candidates Resulting from Searches with    
Noise Gain of 0.4, 0.44 and 0.47. (b) Candidate Stability at Noise Gain  
Values of 0, 0.22, 0.33 and the Sweet Spot 
 
This graph shows that genes MMP12, QPCT, PM20D2, LOC389831 and UGGT2 are the most important since they are at the top 
of the tree and that MMP12, LOC389831 and UGGT2 are hub genes (are in at least one candidate, where they are the most 
connected node, displayed by squares in the figure). The genes in the intermediate section of the network are the “nice-to-have” 
and the end of the trees are the “unique” probes. To distinguish if the “unique” probes are related in some way and the “must-
haves” are contributing new knowledge amongst themselves, pathway analysis is underway. The pathway analysis is being 
conducted by GeneGo’s MetaCore software. (GeneGo, 2010) By analyzing the sixty-two probes, four significant gene pathway 
networks are identified. The first network is for gene ontology (GO) processes that involve cellular component movement, 
locomotion, response to external stimulus, regulation of body fluid levels, and response to chemical stimulus (nodes filled in 
purple). The second network identified is involved in the GO processes of response to wounding, defense response, response to 
stress, response to external stimulus, and regulation of MAPKKK cascade (nodes filled in blue). The third network indentified is 
involved in the GO processes of response to stimulus, transembrane receptor protein serine/theonine kinase signaling pathway, 
enzyme linked receptor protein signaling pathway, growth and immune system process (nodes filled in green). The last network 
identified is involved in the GO processes of regulation of ion transport, potassium ion transport, potassium ion transmembrane 
transport, cellular potassium ion transport, and regulation of ion transmembrane transport (nodes filled in orange). Several of the 
discovered biomarkers (CA9, MMP12, and HLTF) have been implicated in colon cancer progression. (Debauve, et al., 2008; 
Kamochi, et al., 2003; Moinova, et al., 2002; Winum, et al., 2009) Further analysis of this pathway analysis and the further 
biological significance of the identified biomarker sets is ongoing. 
Statistical significance is displayed by a blinded validation dataset. An ensemble of the thirty-eight candidates was developed 
by a majority rule. The classification Az value (ROC area) on the training set was 0.96. The Az value (ROC area) decreased 
significantly to 0.72 on the validation dataset. 
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(b)* 
Figure 3: Gene Networks of 62 probes found in the 38 candidates from sweet spot noise gain searches. (a) Undirected Gene 
Network Graph, where the node (probe) is labeled by its index in the 271 probes. An edge is defined by two nodes being in the 
same candidate. (b) Directed Gene Network Graph, where the node (probe) is labeled by its gene name and the number of 
candidates its appears in. Each edge is defined by the two nodes being in the same candidate with the direction indicating that 
the origin node has more connections than the destination node. *Note that N/K is an acroynm for not known 
 
Gene Set Ave Fitness 
CA9, CD44, CDH11, MMP12, PAH, PM20D2, UGGT2 89.6 
CA9, CCL28, CDH11, MMP12, PAH, PM20D2, PRKAA1, 
UGGT2 85.97 
CA9, CDH11, MMP12, PAH, PM20D2, PRKAA1, UGGT2, 
N/K 77.53 
AKAP12, CA9, HLTF, LOC389831, MMP12, PM20D2, 
QPCT, UGGT2, N/K 86.00 
ANO1, CA9, HLTF, IL1R2, IRAK2, NGFRAP1, UGGT2 79.99 
CA9, MMP12, PM20D2, QPCT, UGGT2, VCAN, N/K, N/K, 
N/K 82.65 
FN1, LOC389831, MMP12, QPCT, UGGT2 83.16 
ADAMTS5, AKAP12, LOC38AKAP1231, MMP12, 
PM20D2, QPCT, ROBO2 77.19 
ADAMTS5, LOC389831, MBNL1, MMP12, PM20D2, 
QPCT, ROBO2 81.70 
ADAMTS5, LOC389831, MMP12, PM20D2, QPCT, 
ROBO2, N/K 80.71 
ADAMTS5, CBFA2T, LOC389831, MMP12, PM20D2, 
QPCT, ROBO2 82.72 
ADAMTS5, LOC389831, MMP12, PM20D2, QPCT, 
ROBO2, SLC22A3 80.79 
ADAMTS5, FN1, LOC389831, MMP12, PM20D2, QPCT, 
ROBO2 86.12 
ADAMTS5, ITGB1, LOC389831, MMP12, PM20D2, QPCT, 
ROBO2 85.98 
ADAMTS5, LOC389831, MMP12, PGAP1, PM20D2, QPCT, 
ROBO2 79.07 
ADAMTS5, LOC389831, MMP12, PM20D2, QPCT, 
ROBO2, N/K 80.77 
ADAMTS5, LOC389831, MMP12, PM20D2, QPCT, 
ROBO2, VPS13A 89.71 
ADAMTS5, DACT1, IGH, LOC389831, MMP12, PM20D2, 
QPCT, ROBO2 77.55 
AKAP12, ANO1, CA9, DLEU2, HLTF, LOC389831, 
MMP12, PGAP1, PM20D2, QPCT, TRIM36, UGGT2 98.89 
Gene Set Ave Fitness 
ANO1, CA9, HLTF, LOC389831, MMP12, PM20D2, QPCT, 
UGGT2 86.29 
ANO1, CA9, HLTF, LOC389831, PM20D2, QPCT, UGGT2 83.87 
AKAP12, ANO1, CA9, HLTF, ITGB1, LOC389831, MMP12, 
PM20D2, QPCT, UGGT2 80.63 
AKAP12, ANO1, CA9, FN1, HLTF, LOC389831, MMP12, 
PM20D2, QPCT, UGGT2 82.65 
AKAP12, ANO1, CA9, CBFA2T, HLTF, LOC389831, 
MMP12, PM20D2, QPCT, UGGT2 90.46 
AKAP12, ANO1, CA9, CCL20, HLTF, MMP12, PM20D2, 
QPCT, UGGT2 82.37 
CA9, LOC389831, QPCT, ROBO2, UGGT2, N/K 80.82 
CA9, DLG1, LOC389831, MMP12, NGFRAP1,TRIM36, 
PM20D2, QPCT, UGGT2, N/K 82.69 
AKAP12, CA9, HLTF, MMP12, PM20D2, QPCT, UGGT2, 
N/K 86.23 
ANO1, CA9, HLTF, LOC389831, PM20D2, TRIM36, N/K, 
N/K 82.46 
ADAMTS5, CA9, IRAK2, LOC389831, MMP12, ROBO2, 
UGGT2 79.75 
ADAMTS5, CA9, IRAK2, LOC389831, MMP12, PM20D2, 
QPCT, ROBO2, UGGT2, N/K 86.35 
ADAMTS5, CA9, CCL23, IRAK2, LOC389831, MMP12, 
PM20D2, QPCT, ROBO2, UGGT2 89.16 
ADAMTS5, CA9, IRAK2, LOC389831, MMP12, PM20D2, 
QPCT, ROBO2, UGGT2, VLDLR 79.91 
LOC389831, MMP12, PAH, PM20D2, QPCT, SPP1, 
TRIM36, ZNF503, N/K 94.55 
FST, H19, HLTF,SLC22A3, IGHM, IRAK2, LOC389831, 
PAH, UGGT2 77.88 
CA9, CXCR6, DACT1, LOC389831, MMP12, QPCT, 
ROBO2, UGGT2, N/K 94.44 
IGH, KIAA0485, LOC389831, MMP12, PM20D2, QPCT, 
N/K 83.22 
GDAP1, IGH, LOC389831, MMP12, PM20D2, QPCT, N/K 88.62 
Table 2: Thirty-Eight Candidate Biomarker Gene Sets for the Prognosis of Colon Cancer. Gene sets are sorted in alphabetical 
order. *Note that N/K is an acronym for not known. 
(a) 
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4. Conclusions 
A wrapper feature selection technique of a genetic algorithm and support vector machine (GA-SVM) hybrid is presented to 
perform feature selection on gene expression microarray data to find biomarker sets of minimal size for the prognosis of colon 
cancer. The trouble in such analysis is the high risk of over-fitting, mainly due to the under-determined nature of the data. The 
GA-SVM hybrid alone continues to shows sign of over-fitting, since the biomarkers discovered had very little similarity. Noise 
perturbation was introduced into the system to find the strongest signal in the data, thus finding relatively stable biomarker sets. 
The stability in the discovered biomarker sets was shown by hierarchical cluster analysis of candidates from common noise gain 
searches. The total dissimilarity of discovered biomarker sets in the sweet spot does in fact stabilize. To validate and characterize 
the diversity in the discovered biomarker sets, gene pathway and network analysis has been conducted, which show that several 
genes are “must-haves” in the set, others are “nice-to-have” and finally others are “uniques”. The biology and complete pathway 
information about the biomarker genes sets discovered should be studied further and their biological relevance should be 
accessed. An ensemble classifier of the thirty-eight candidates analyzed, displayed a significant drop in performance of the 
discovered candidates between the training and validation sets. Such a system  provides evidence that the strongest signal in the 
data is spurious and not generalizable to a large population. 
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